Stockscreener 앱 받기
1.72
6.01%
-0.11
시간 외 거래:
1.71
-0.01
-0.58%
전일 마감가:
$1.83
열려 있는:
$1.79
하루 거래량:
1.43M
Relative Volume:
0.63
시가총액:
$70.08M
수익:
$68.68M
순이익/손실:
$-60.84M
주가수익비율:
-1.075
EPS:
-1.6
순현금흐름:
$-38.42M
1주 성능:
-13.13%
1개월 성능:
-6.52%
6개월 성능:
-54.38%
1년 성능:
-75.84%
1일 변동 폭
$1.66
$1.79
1주일 범위
$1.66
$2.1192
52주 변동 폭
$1.47
$9.37
풀몬스 Stock (LUNG) Company Profile
명칭
Pulmonx Corp
전화
650-364-0400
주소
700 CHESAPEAKE DRIVE, REDWOOD CITY
LUNG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.72 | 74.57M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
125.84 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
풀몬스 Stock (LUNG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-31 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | 개시 | D. Boral Capital | Buy |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-04 | 개시 | Lake Street | Buy |
| 2024-02-23 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 개시 | Craig Hallum | Buy |
| 2023-02-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Neutral |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-10-26 | 개시 | BofA Securities | Buy |
| 2020-10-26 | 개시 | Canaccord Genuity | Buy |
| 2020-10-26 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 개시 | Stifel | Buy |
| 2020-10-26 | 개시 | Wells Fargo | Equal Weight |
모두보기
풀몬스 주식(LUNG)의 최신 뉴스
Is Pulmonx Corporation stock entering bullish territoryJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
A better buy-in window may exist right now for Pulmonx Corp (LUNG) - setenews.com
Will Pulmonx Corporation stock maintain momentum in 20252025 Sector Review & Safe Entry Point Alerts - newser.com
Can Pulmonx Corporation stock outperform in 2025 bull market2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Technical signs of recovery in Pulmonx Corporation2025 Price Action Summary & Weekly Stock Performance Updates - newser.com
Visualizing Pulmonx Corporation stock with heatmapsWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - newser.com
What catalysts could drive Pulmonx Corporation stock higherEarnings Performance Report & Low Volatility Stock Recommendations - newser.com
Using data filters to optimize entry into Pulmonx CorporationJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast - AD HOC NEWS
Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? - Insider Monkey
Is Pulmonx Corporation reversing from oversold territoryWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Historical volatility pattern of Pulmonx Corporation visualizedChart Signals & High Accuracy Swing Trade Signals - newser.com
Why Pulmonx Corporation stock remains on watchlistsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Is this a good reentry point in Pulmonx CorporationJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Pulmonx (NASDAQ:LUNG) Given New $14.00 Price Target at D. Boral Capital - MarketBeat
Pulmonx (LUNG) Anticipates Q3 Revenue of $21.5 Million - GuruFocus
What hedge fund activity signals for Pulmonx Corporation stockRecession Risk & Daily Profit Maximizing Tips - newser.com
Tick level data insight on Pulmonx Corporation volatilityMarket Activity Summary & Entry Point Strategy Guides - newser.com
Lake Street Lowers Price Target for Pulmonx (LUNG) Amidst Mainta - GuruFocus
LUNG’s Surprise Revenue Surge: Key Factors - StocksToTrade
Pulmonx brings back former CEO amid leadership shakeup - Investing.com India
Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Exp - GuruFocus
Canaccord Genuity reiterates Buy rating on Pulmonx stock amid leadership changes - Investing.com Nigeria
Using Python tools to backtest Pulmonx Corporation strategiesDip Buying & Fast Gain Stock Tips - newser.com
D. Boral Capital Maintains Pulmonx (LUNG) Buy Recommendation - Nasdaq
Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Analyst Lowers Price Target for Pulmonx (LUNG) While Maintaining Buy Rating | LUNG Stock News - GuruFocus
Pulmonx brings back former CEO amid leadership shakeup By Investing.com - Investing.com Australia
How Pulmonx Corporation stock compares to market leaders2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates - Nasdaq
Pulmonx Corp (LUNG) Q3 2025 Earnings: Revenue Surpasses Estimates at $21.5 Million - GuruFocus
LUNG to Discuss Q3 2025 Results and Annual Outlook in November C - GuruFocus
Pulmonx Announces Leadership Changes with New CEO - TipRanks
Pulmonx announces management transition and preliminary third quarter 2025 revenue reschedules third quarter 2025 earnings call to November 12, 2025 - MarketScreener
Pulmonx Announces Management Transition And Preliminary Third Quarter 2025 Revenue Reschedules Third Quarter 2025 Earnings Call To November 12, 2025 - TradingView
Pulmonx Corporation Announces Leadership Transition and Preliminary Third Quarter 2025 Revenue Estimates - Quiver Quantitative
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - The Manila Times
Pulmonx Corporation Announces CEO Changes, Effective October 27, 2025 - MarketScreener
Pulmonx (Nasdaq: LUNG) reappoints Glen French as CEO; preliminary Q3 revenue ~$21.5M - Stock Titan
풀몬스 (LUNG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.23%
자본화:
|
볼륨(24시간):